Low Risk Low Risk Low Risk Intermediate Risk Intermediate Risk Intermediate Risk High Risk High Risk High Risk
G1 G2 p* G1 G2 p* G1 G2 p*
PSA Recurrence n (%)
-
589 (89.92)
148 (91.36)
0.582
629 (85.69)
129 (86.0)
0.922
178 (67.17)
48 (80.0)
0.051
+ 66 (10.08) 14 (8.64) 105 (14.31) 21 (14.0) 87 (32.83) 12 (20.0)
Additional Therapy n (%)
-
603 (92.06)
147 (90.74)
0.583
609 (82.97)
121 (80.67)
0.498
157 (59.25)
45 (75.0)
0.023
+ 52 (7.94) 15 (9.26) 125 (17.03) 29 (19.33) 108 (40.75) 15 (25.0)
Metastasis on Follow Up n (%)
-
649 (99.08)
160 (98.77)
0.712
713 (97.14)
144 (96.0)
0.460
243 (91.7)
55 (91.67)
0.994
+
6 (0.92) 2 (1.23)
21 (2.86)
6 (4.0) 22 (8.3) 5 (8.33)